238 related articles for article (PubMed ID: 6454739)
1. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.
Howard JG; Hale C; Liew FY
J Exp Med; 1981 Mar; 153(3):557-68. PubMed ID: 6454739
[TBL] [Abstract][Full Text] [Related]
2. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
Howard JG; Hale C; Liew FY
J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
[TBL] [Abstract][Full Text] [Related]
3. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
Liew FY; Hale C; Howard JG
J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
Alexander J; Kaye PM
Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
Sacks DL; Scott PA; Asofsky R; Sher FA
J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
Liew FY; Singleton A; Cillari E; Howard JG
J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
[TBL] [Abstract][Full Text] [Related]
8. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
9. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
Müller I; Pedrazzini T; Kropf P; Louis J; Milon G
Int Immunol; 1991 Jun; 3(6):587-97. PubMed ID: 1909563
[TBL] [Abstract][Full Text] [Related]
10. Specific suppression of responses to Leishmania tropica by a cloned T-cell line.
Liew FY
Nature; 1983 Oct 13-19; 305(5935):630-2. PubMed ID: 6604879
[TBL] [Abstract][Full Text] [Related]
11. Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis.
Dhaliwal JS; Liew FY; Cox FE
Infect Immun; 1985 Aug; 49(2):417-23. PubMed ID: 3160663
[TBL] [Abstract][Full Text] [Related]
12. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.
Liew FY; Millott S; Lelchuk R; Cobbold S; Waldmann H
Clin Exp Immunol; 1989 Mar; 75(3):438-43. PubMed ID: 2784747
[TBL] [Abstract][Full Text] [Related]
13. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
Mitchell GF
J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
[TBL] [Abstract][Full Text] [Related]
14. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.
Hill JO; Awwad M; North RJ
J Exp Med; 1989 May; 169(5):1819-27. PubMed ID: 2523955
[TBL] [Abstract][Full Text] [Related]
15. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
Dhaliwal JS; Liew FY
Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
[TBL] [Abstract][Full Text] [Related]
16. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
Moll H; Mitchell GF
J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
[TBL] [Abstract][Full Text] [Related]
17. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
De Rossell RA; Bray RS; Alexander J
Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
Varkila K; Chatelain R; Leal LM; Coffman RL
Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
Lelchuk R; Graveley R; Liew FY
Cell Immunol; 1988 Jan; 111(1):66-76. PubMed ID: 3257416
[TBL] [Abstract][Full Text] [Related]
20. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.
Handman E; Ceredig R; Mitchell GF
Aust J Exp Biol Med Sci; 1979 Feb; 57(1):9-29. PubMed ID: 314286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
